Imatinib Mesylate

Rediff.com » News » Imatinib Mesylate

News for Imatinib Mesylate

Business

Dr Reddy's A-team moves on putting house in order

After spending considerable time and energy in remediation efforts in the wake of the US Food and Drug Administration's warning letter on compliance issues, the company's leadership has finally set......

Markets settle near 3-week low; ITC tanks nearly 7%

Markets closed lower for the fourth session closing near three-week low with ITC contributing the most to the decline after Arvind Subramanian-led GST panel suggested that tobacco products......

Sun Pharma sues Novartis in US court

In a development that could hasten the entry of the generic version of Gleevec into the US market, Indian drug major Sun Pharma has sued Novartis Pharmaceuticals Corp in the District Court of New......

'Novartis case: SC ruling wise and balanced'

The Supreme Court recently rejected the plea of Novartis AG for patent protection of its anti-cancer drug Glivec.The Supreme Court judgement (pages 22 -26) quite extensively quoted from Sudip......

COLUMN: SC right to reject Novartis's attempt

Novartis’ threat that it would not introduce new medicines in India after the verdict is hollow, says Anand Grover.While the patients and the generic companies have rejoiced over the Supreme......

Rediff News

Imatinib Mesylate

News for Imatinib Mesylate

Dr Reddy's A-team moves on putting house in order

Markets settle near 3-week low; ITC tanks nearly 7%

Sun Pharma sues Novartis in US court

'Novartis case: SC ruling wise and balanced'

COLUMN: SC right to reject Novartis's attempt

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS